| Dr Richard Lee, MD | |
|
177 N Dean St # 305, Englewood, NJ 07631-2533 | |
| (201) 569-7777 | |
| (201) 569-6861 |
| Full Name | Dr Richard Lee |
|---|---|
| Gender | Male |
| Speciality | Urology |
| Experience | 29 Years |
| Location | 177 N Dean St # 305, Englewood, New Jersey |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1225110570 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208800000X | Urology | 25MA07241400 (New Jersey) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Holy Name Medical Center | Teaneck, NJ | Hospital |
| New York-presbyterian Hospital | New york, NY | Hospital |
| Englewood Hospital And Medical Center | Englewood, NJ | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Excelcare Medical Associates Pa | 4284647868 | 182 |
News Archive
Indiana University School of Medicine and Regenstrief Institute research scientists have received a $3.4 million award from the Patient-Centered Outcomes Research Institute to investigate the best care options for the 40 percent of people who go to the hospital emergency department with chest pain that is determined to be caused by anxiety rather than a cardiac event.
The AIDS Institute, a national public policy research, advocacy, and education organization, is encouraged with the FDA's approval of the first new non-nucleoside reverse transcriptase inhibitor (NNRTI) in nearly a decade.
The largest study ever of its kind, led by researchers from McMaster University and the University of Toronto, has found that a routine strategy of blood clot removal during treatment for heart attacks was not beneficial and was associated with an increased risk of stroke.
Researchers have created a new method for screening cells used in immunotherapy cancer treatments, allowing high-performing immune system cells to be studied in isolation and potentially expanding the number of patients for whom the breakthrough treatment proves successful.
› Verified 2 days ago
| Entity Name | Urologic Specialties Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1154403418 PECOS PAC ID: 0547204414 Enrollment ID: O20050613000801 |
News Archive
Indiana University School of Medicine and Regenstrief Institute research scientists have received a $3.4 million award from the Patient-Centered Outcomes Research Institute to investigate the best care options for the 40 percent of people who go to the hospital emergency department with chest pain that is determined to be caused by anxiety rather than a cardiac event.
The AIDS Institute, a national public policy research, advocacy, and education organization, is encouraged with the FDA's approval of the first new non-nucleoside reverse transcriptase inhibitor (NNRTI) in nearly a decade.
The largest study ever of its kind, led by researchers from McMaster University and the University of Toronto, has found that a routine strategy of blood clot removal during treatment for heart attacks was not beneficial and was associated with an increased risk of stroke.
Researchers have created a new method for screening cells used in immunotherapy cancer treatments, allowing high-performing immune system cells to be studied in isolation and potentially expanding the number of patients for whom the breakthrough treatment proves successful.
› Verified 2 days ago
| Entity Name | Excelcare Medical Associates Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1992736300 PECOS PAC ID: 4284647868 Enrollment ID: O20060727000044 |
News Archive
Indiana University School of Medicine and Regenstrief Institute research scientists have received a $3.4 million award from the Patient-Centered Outcomes Research Institute to investigate the best care options for the 40 percent of people who go to the hospital emergency department with chest pain that is determined to be caused by anxiety rather than a cardiac event.
The AIDS Institute, a national public policy research, advocacy, and education organization, is encouraged with the FDA's approval of the first new non-nucleoside reverse transcriptase inhibitor (NNRTI) in nearly a decade.
The largest study ever of its kind, led by researchers from McMaster University and the University of Toronto, has found that a routine strategy of blood clot removal during treatment for heart attacks was not beneficial and was associated with an increased risk of stroke.
Researchers have created a new method for screening cells used in immunotherapy cancer treatments, allowing high-performing immune system cells to be studied in isolation and potentially expanding the number of patients for whom the breakthrough treatment proves successful.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Richard Lee, MD 177 N Dean St # 305, Englewood, NJ 07631-2533 Ph: (201) 569-7777 | Dr Richard Lee, MD 177 N Dean St # 305, Englewood, NJ 07631-2533 Ph: (201) 569-7777 |
News Archive
Indiana University School of Medicine and Regenstrief Institute research scientists have received a $3.4 million award from the Patient-Centered Outcomes Research Institute to investigate the best care options for the 40 percent of people who go to the hospital emergency department with chest pain that is determined to be caused by anxiety rather than a cardiac event.
The AIDS Institute, a national public policy research, advocacy, and education organization, is encouraged with the FDA's approval of the first new non-nucleoside reverse transcriptase inhibitor (NNRTI) in nearly a decade.
The largest study ever of its kind, led by researchers from McMaster University and the University of Toronto, has found that a routine strategy of blood clot removal during treatment for heart attacks was not beneficial and was associated with an increased risk of stroke.
Researchers have created a new method for screening cells used in immunotherapy cancer treatments, allowing high-performing immune system cells to be studied in isolation and potentially expanding the number of patients for whom the breakthrough treatment proves successful.
› Verified 2 days ago
Dr. John F Kerns, MD Urology Medicare: Not Enrolled in Medicare Practice Location: 177 N Dean St, Englewood, NJ 07631 Phone: 201-569-7777 Fax: 210-569-6861 | |
Philip S Affuso, MD Urology Medicare: Not Enrolled in Medicare Practice Location: 177 N Dean St, Englewood, NJ 07631 Phone: 201-569-7777 Fax: 201-569-6861 | |
Steven Katz, Urology Medicare: Medicare Enrolled Practice Location: 300 Grand Ave, Suite 202, Englewood, NJ 07631 Phone: 201-816-1900 Fax: 201-816-1777 | |
Raymond B Andronaco, MD Urology Medicare: Not Enrolled in Medicare Practice Location: 177 N Dean St # 305, Englewood, NJ 07631 Phone: 201-569-7777 Fax: 201-569-6861 | |
Chester C Lee, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 177 N Dean St, Englewood, NJ 07631 Phone: 201-569-7777 |